Name (Synonyms) | Correlation | |
---|---|---|
drug417 | Impact of Event Scale-Revised Wiki | 1.00 |
drug216 | Connor-Davidson Resilience Scale 10 items (CD-RISC 10) Wiki | 1.00 |
drug136 | Brief Psychiatric Rating Scale Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D000066553 | Problem Behavior NIH | 0.71 |
D004194 | Disease NIH | 0.50 |
D001523 | Mental Disorders NIH | 0.41 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
Given the possible risks and complications of a comorbidity between psychiatric disorder and coronavirus disease 2019 (COVID-19), it seems particularly important to specify the impact of the COVID-19 pandemic in patients with psychiatric disorders and suspected of infection, hospitalized in a specific unit, at the psychiatric, somatic and pharmacological level.
Description: total severity score from the Impact of Event Scale-Revised (IES-R)
Measure: impact of the COVID-19 pandemic on psychiatric symptomatology Time: through study completion, an average of 2 year